Pages that link to "Q48421302"
Jump to navigation
Jump to search
The following pages link to Disinhibitory effects of buspirone and low doses of sulpiride and haloperidol in two experimental anxiety models in rats: possible role of dopamine (Q48421302):
Displaying 28 items.
- Sulpiride and refractory panic disorder (Q28272521) (← links)
- D3 dopamine receptor-deficient mouse: evidence for reduced anxiety (Q28509689) (← links)
- Effects of typical and atypical antipsychotic drugs on freezing behavior induced by conditioned fear (Q34410109) (← links)
- The Vogel conflict test: procedural aspects, gamma-aminobutyric acid, glutamate and monoamines (Q35071483) (← links)
- The neurobiology and control of anxious states (Q35202929) (← links)
- Levo-Tetrahydroberberrubine Produces Anxiolytic-Like Effects in Mice through the 5-HT1A Receptor (Q36249054) (← links)
- Animal models of drug withdrawal symptoms (Q37591747) (← links)
- Effects of SCH-23390 in combination with a low dose of 17β-estradiol on anxiety-like behavior in ovariectomized rats. (Q37636154) (← links)
- Serotonin receptors: clinical implications (Q37914869) (← links)
- Differential effects of dopaminergic drugs on anxiety and arousal in healthy volunteers with high and low anxiety (Q39455872) (← links)
- 5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: More than 30 years of research (Q40465103) (← links)
- Anti-conflict efficacy of buspirone following acute versus chronic treatment (Q41283035) (← links)
- Serotonin does not mediate anxiolytic effects of buspirone in the fear-potentiated startle paradigm: comparison with 8-OH-DPAT and ipsapirone (Q41346194) (← links)
- Evidence that central 5-hydroxytryptaminergic neurones are involved in the anxiolytic activity of buspirone (Q41899150) (← links)
- Anxiolytic effects of buspirone and gepirone in the fear-potentiated startle paradigm (Q42037314) (← links)
- Prevention of the analgesic consequences of social defeat in male mice by 5-HT1A anxiolytics, buspirone, gepirone and ipsapirone (Q42495046) (← links)
- 5-HT1A receptor-dependent modulation of emotional and neurogenic deficits elicited by prolonged consumption of alcohol (Q47639179) (← links)
- Neurochemical and behavioural studies with RU-24969 in the rat. (Q48153140) (← links)
- Potential anxiolytic properties of 8-hydroxy-2-(di-n-propylamino)tetralin, a selective serotonin 1A receptor agonist (Q48161557) (← links)
- Prior test experience compromises the anxiolytic efficacy of chlordiazepoxide in the mouse light/dark exploration test (Q48678705) (← links)
- Evidence for the involvement of 5-HT1A receptors in the anticonflict effect of ipsapirone in rats (Q48703294) (← links)
- Antagonism of amphetamine-induced disruption of latent inhibition in rats by haloperidol and ondansetron: implications for a possible antipsychotic action of ondansetron. (Q51134758) (← links)
- Ethological evaluation of the effects of acute and chronic buspirone treatment in the murine elevated plus-maze test: comparison with haloperidol. (Q51136059) (← links)
- Anxiolytic effects of dopamine receptor ligands: I. Involvement of dopamine autoreceptors. (Q51530069) (← links)
- The discriminative stimulus properties of buspirone involve dopamine-2 receptor antagonist activity. (Q52228724) (← links)
- Behavioral and neurochemical effects of the serotonin (5-HT)1A receptor ligand spiroxatrine. (Q52248786) (← links)
- Buspirone affects hippocampal rhythmical slow activity through serotonin1A rather than dopamine D2 receptors (Q67900241) (← links)
- [Buspirone: pharmacological and clinical properties of the first member of a new anxiolytic drug family] (Q68138033) (← links)